1. Amaliin K, Hirai M, Aktar S, Koshizuka T, Mori Y, *Arii J. Host-directed clearance of nuclear tegument U14 terminates NF-κB signaling and supports HHV-6A replication. PLoS Pathogens. 22(9): e1014576, 2026
  2. *Arii J+, Aktar S+, Huang JR, Hirai M, Kawamura Y, Miura H, Wang B, Nagamata S, Nishimura M, Yoshikawa T, Harris RS, Mori Y. A viral APOBEC3 antagonist distinguishes HHV-6A from HHV-6B. Nature communications 17(1) 3566. 2026
  3. Amaliin K, Gulijiahani A, Hirai M, Mori Y, *Arii J. Conserved U14-Mediated NF-κB Activation in Human Herpesvirus 6A and 6B. Microbiology and Immunology 70(6) 321-329 2026

*； corresponding author, +； co-first

  1. Gulijiahani A+, *Arii J+, Isakovic V, Huang J, Kawaguchi Y, Mori Y. ESCRT-III is recruited by human herpesvirus 6A nuclear egress complex to promote nuclear egress of the nucleocapsid. Journal of virology 99(9) 2025
  2. Gulijiahani A, Isakovic V, Mori Y, *Arii J. Comparative Analysis of the Nuclear Egress Complex in Human Herpesvirus 6A and 6B. Microbiology and Immunology 69(10) 502-510 2025
  3. Hirai M, Amaliin K, Huang J, Aktar S, Mori Y, *Arii J. HHV-6B ribonucleotide reductase sequesters NF-κB subunit p65 to inhibit innate immune responses. iScience, 28(2):111710. 2025
  4. Huang J, *Arii J, Hirai M, Nishimura M, Mori Y. Human herpesvirus 6A nuclear matrix protein U37 interacts with heat shock transcription factor 1 and activates the heat shock response. Journal of virology 97(9) e0071823 2023
  5. Sutandhio S, Furukawa K, Kurahashi Y, Marini M, Effendi G, Hasegawa N, Ishimaru H, Nishimura M, Arii J, Mori Y. Fourth mRNA vaccination increases cross-neutralizing antibody titers against SARS-CoV-2 variants, including BQ.1.1 and XBB, in a very elderly population. Journal of infection and public health 16(7) 1064-1072 2023
  6. Ishimaru H, Nishimura M, Tjan LH, Sutandhio S, Marini MI, Effendi GB, Shigematsu H, Kato K, Hasegawa N, Aoki K, Kurahashi Y, Furukawa K, Shinohara M, Nakamura T, Arii J, Nagano T, Nakamura S, Sano S, Iwata S, Okamura S, Mori Y. Identification and Analysis of Monoclonal Antibodies with Neutralizing Activity against Diverse SARS-CoV-2 Variants. Journal of virology e0028623 2023
  7. Furukawa K, Kurahashi Y, Ishimaru H, Nishimura M, Arii J, Sano S, Tohma Y, Ohkita H, Nakamura S, Iwata S, Mori Y. The Number of Coronavirus Disease 2019 Vaccine Doses and Severe Clinical Outcomes in Older Patients Infected With a Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant. The Journal of infectious diseases 226(11) 2041-2042 2022
  8. Aktar S+, *Arii J+, Nguyen TTH, Huang JR, Nishimura M, Mori Y. ATF1 Restricts Human Herpesvirus 6A Replication via Beta Interferon Induction. Journal of virology 96(19) e0126422 2022
  9. Kurahashi Y, Furukawa K, Sutandhio S, Tjan LH, Iwata S, Sano S, Tohma Y, Ohkita H, Nakamura S, Nishimura M, Arii J, Kiriu T, Yamamoto M, Nagano T, Nishimura Y, Mori Y. Cross-neutralizing activity against Omicron could be obtained in SARS-CoV-2 convalescent patients who received two doses of mRNA vaccination. The Journal of infectious diseases 226(8) 1391-1395 2022
  10. Furukawa K, Tjan LH, Kurahashi Y, Sutandhio S, Nishimura M, Arii J, Mori Y. Assessment of Neutralizing Antibody Response Against SARS-CoV-2 Variants After 2 to 3 Doses of the BNT162b2 mRNA COVID-19 Vaccine. JAMA network open 5(5) e2210780 2022
  11. Tjan LH, Furukawa K, Kurahashi Y, Sutandhio S, Nishimura M, Arii J, Mori Y. Induction of High Neutralizing Activity Against Both Omicron BA.2 and Omicron BA.1 by Coronavirus Disease 2019 Messenger RNA Booster Vaccination. The Journal of Infectious Diseases 226(8) 1481-1483 2022
  12. Maeda F, Kato A, Takeshima K, Shibazaki M, Sato R, Shibata T, Miyake K, Kozuka-Hata H, Oyama M, Shimizu E, Imoto S, Miyano S, Adachi S, Natsume T, Takeuchi K, Maruzuru Y, Koyanagi N, Arii J, Kawaguchi Y. Role of the Orphan Transporter SLC35E1 in the Nuclear Egress of Herpes Simplex Virus 1. Journal of virology 96(10) e0030622 2022
  13. Arii J, Takeshima K, Maruzuru Y, Koyanagi N, Nakayama Y, Kato A, Mori Y, Kawaguchi Y. Role of the arginine cluster in the disordered domain of Herpes Simplex Virus 1 UL34 for the recruitment of ESCRT-III for viral primary envelopment. Journal of virology 96(2) e0170421. 2022
  14. Kurahashi Y, Sutandhio S, Furukawa K, Tjan LH, Iwata S, Sano S, Tohma Y, Ohkita H, Nakamura S, Nishimura M, Arii J, Kiriu T, Yamamoto M, Nagano T, Nishimura Y, Mori Y. Cross-Neutralizing Breadth and Longevity Against SARS-CoV-2 Variants After Infections. Frontiers in immunology 13 773652-773652 2022
  15. Ren Z, Nishimura M, Tjan LH, Furukawa K, Kurahashi Y, Sutandhio S, Aoki K, Hasegawa N, Arii J, Uto K, Matsui K, Sato I, Saegusa J, Godai N, Takeshita K, Yamamoto M, Nagashima T, Mori Y. Large-scale serosurveillance of COVID-19 in Japan: Acquisition of neutralizing antibodies for Delta but not for Omicron and requirement of booster vaccination to overcome the Omicron's outbreak. PloS one 17(4) e0266270 2022
  16. Aktar S, *Arii J, Tjan LH, Nishimura M, Mori Y. Human herpesvirus 6A tegument protein U14 induces NF-κB signaling by interacting with p65. Journal of virology 95(23) 2021
  17. Furukawa K, Tjan LH, Sutandhio S, Kurahashi Y, Iwata S, Tohma Y, Sano S, Nakamura S, Nishimura M, Arii J, Kiriu T, Yamamoto M, Nagano T, Nishimura Y, Mori Y. Cross-Neutralizing Activity Against SARS-CoV-2 Variants in COVID-19 Patients: Comparison of 4 Waves of the Pandemic in Japan. Open forum infectious diseases 8(10) ofab430 2021
  18. Wakata A, Tjan LH, Nishimura M, Kawabata A, Poetranto AL, Yamamoto C, Arii J, Mori Y. The Combination of gQ1 and gQ2 in Human Herpesvirus 6A and 6B Regulates the Viral Tetramer Function for Their Receptor Recognition. Journal of virology 95(5) 2021
  19. Furukawa K+, Arii J+, Nishimura M+, Tjan LH, Lystia Poetranto A, Ren Z, Aktar S, Huang JR, Sutandhio S, Kurahashi Y, Nishino A, Shigekuni S, Takeda Y, Uto K, Matsui K, Sato I, Inui Y, Endo K, Kosaka Y, Oota T, Saegusa J, Mori Y. Seroepidemiological Survey of the Antibody for Severe Acute Respiratory Syndrome Coronavirus 2 with Neutralizing Activity at Hospitals: A Cross-sectional Study in Hyogo Prefecture, Japan. JMA journal 4(1) 41-49 2021
  20. Tjan LH, Furukawa K, Nagano T, Kiriu T, Nishimura M, Arii J, Hino Y, Iwata S, Nishimura Y, Mori Y. Early differences in cytokine production distinguish severity of COVID-19. The Journal of infectious diseases 223(7) 1145-1149 2021
  21. Watanabe M+, Arii J+, Takeshima K, Fukui A, Shimojima M, Kozuka-Hata H, Oyama M, Minamitani T, Yasui T, Kubota Y, Takekawa M, Kosugi I, Maruzuru Y, Koyanagi N, Kato A, Mori Y, Kawaguchi Y. Prohibitin-1 Contributes to the Cell-to-Cell Transmission of Herpes Simplex Virus 1. Journal of virology 95(3) 2020
  22. Arii J, Maeda F, Maruzuru Y, Koyanagi N, Kato A, Mori Y, Kawaguchi Y. ESCRT-III controls nuclear envelope deformation induced by progerin. Scientific reports 10(1) 18877-18877 2020
  23. Arii J, Fukui A, Shimanaka Y, Kono N, Arai H, Maruzuru Y, Koyanagi N, Kato A, Mori Y, Kawaguchi Y. Role of phosphatidyl-ethanolamine biosynthesis in herpes simplex virus 1 infected cells on progeny virus morphogenesis in the cytoplasm and on viral pathogenicity in vivo. Journal of virology 94(24) 2020
  24. Kato A+, Adachi S+, Kawano S, Takeshima K, Watanabe M, Kitazume S, Sato R, Kusano H, Koyanagi N, Maruzuru Y, Arii J, Hatta T, Natsume T, Kawaguchi Y. Identification of a herpes simplex virus 1 gene encoding neurovirulence factor by chemical proteomics. Nature communications 11(1) 4894-4894 2020
  25. Poetranto AL, Wakata A, Tjan LH, Nishimura M, Arii J, Mori Y. Human herpesvirus 6A U27 plays an essential role for the virus propagation. Microbiology and immunology 64(10) 703-711 2020
  26. Nagano T+, Arii J+, Nishimura M+, Yoshida N, Iida K, Nishimura Y, Mori Y. Diligent medical activities of a publicly designated medical institution for infectious diseases pave the way for overcoming COVID-19: A positive message to people working at the cutting edge. Clinical Infectious Diseases 72(4) 723-724 2020
  27. Takeshima K+, Arii J+, Maruzuru Y, Koyanagi N, Kato A, Kawaguchi Y. Identification of the Capsid Binding Site in the Herpes Simplex Virus 1 Nuclear Egress Complex and Its Role in Viral Primary Envelopment and Replication. Journal of virology 93(21) 2019
  28. Arii J, Takeshima K, Maruzuru Y, Koyanagi N, Kato A, Kawaguchi Y. Roles of the Interhexamer Contact Site for Hexagonal Lattice Formation of the Herpes Simplex Virus 1 Nuclear Egress Complex in Viral Primary Envelopment and Replication. Journal of virology 93(14) 2019
  29. Arii J, Watanabe M, Maeda F, Tokai-Nishizumi N, Chihara T, Miura M, Maruzuru Y, Koyanagi N, Kato A, Kawaguchi Y. ESCRT-III mediates budding across the inner nuclear membrane and regulates its integrity. Nature communications 9(1) 3379-3379 2018
  30. Sato R, Kato A, Chimura T, Saitoh SI, Shibata T, Murakami Y, Fukui R, Liu K, Zhang Y, Arii J, Sun-Wada GH, Wada Y, Ikenoue T, Barber GN, Manabe T, Kawaguchi Y, Miyake K. Combating herpesvirus encephalitis by potentiating a TLR3-mTORC2 axis. Nature immunology 19(10) 1071-1082 2018
  31. Kato A, Oda S, Watanabe M, Oyama M, Kozuka-Hata H, Koyanagi N, Maruzuru Y, Arii J, Kawaguchi Y. Roles of the Phosphorylation of Herpes Simplex Virus 1 UL51 at a Specific Site in Viral Replication and Pathogenicity. Journal of virology 92(18) 2018
  32. Koyanagi N, Kato A, Takeshima K, Maruzuru Y, Kozuka-Hata H, Oyama M, Arii J, Kawaguchi Y. Regulation of Herpes Simplex Virus 2 Protein Kinase UL13 by Phosphorylation and Its Role in Viral Pathogenesis. Journal of virology 92(17) 2018
  33. Maruzuru Y, Ichinohe T, Sato R, Miyake K, Okano T, Suzuki T, Koshiba T, Koyanagi N, Tsuda S, Watanabe M, Arii J, Kato A, Kawaguchi Y. Herpes Simplex Virus 1 VP22 Inhibits AIM2-Dependent Inflammasome Activation to Enable Efficient Viral Replication. Cell host & microbe 23(2) 254-265 2018
  34. Koyanagi N, Imai T, Shindo K, Sato A, Fujii W, Ichinohe T, Takemura N, Kakuta S, Uematsu S, Kiyono H, Maruzuru Y, Arii J, Kato A, Kawaguchi Y. Herpes simplex virus-1 evasion of CD8+ T cell accumulation contributes to viral encephalitis. The Journal of clinical investigation 127(10) 3784-3795 2017
  35. Kobayashi R, Kato A, Sagara H, Watanabe M, Maruzuru Y, Koyanagi N, Arii J, Kawaguchi Y. Herpes Simplex Virus 1 Small Capsomere-Interacting Protein VP26 Regulates Nucleocapsid Maturation. Journal of virology 91(18) 2017
  36. Maeda F, Arii J, Hirohata Y, Maruzuru Y, Koyanagi N, Kato A, Kawaguchi Y. Herpes Simplex Virus 1 UL34 Protein Regulates the Global Architecture of the Endoplasmic Reticulum in Infected Cells. Journal of virology 91(12) 2017
  37. Arii J, Shindo K, Koyanagi N, Kato A, Kawaguchi Y. Multiple Roles of the Cytoplasmic Domain of Herpes Simplex Virus 1 Envelope Glycoprotein D in Infected Cells. Journal of virology 90(22) 10170-10181 2016
  38. Oda S, Arii J, Koyanagi N, Kato A, Kawaguchi Y. The Interaction between Herpes Simplex Virus 1 Tegument Proteins UL51 and UL14 and Its Role in Virion Morphogenesis. Journal of virology 90(19) 8754-67 2016
  39. Maruzuru Y, Koyanagi N, Takemura N, Uematsu S, Matsubara D, Suzuki Y, Arii J, Kato A, Kawaguchi Y. p53 Is a Host Cell Regulator during Herpes Simplex Encephalitis. Journal of virology 90(15) 6738-6745 2016
  40. Kato A, Ando T, Oda S, Watanabe M, Koyanagi N, Arii J, Kawaguchi Y. Roles of Us8A and Its Phosphorylation Mediated by Us3 in Herpes Simplex Virus 1 Pathogenesis. Journal of virology 90(12) 5622-5635 2016
  41. Sato Y, Kato A, Maruzuru Y, Oyama M, Kozuka-Hata H, Arii J, Kawaguchi Y. Ubiquitin-specific protease 9X in host cells interacts with herpes simplex virus 1 ICP0. The Journal of veterinary medical science 78(3) 405-10 2016
  42. Sato Y, Kato A, Arii J, Koyanagi N, Kozuka-Hata H, Oyama M, Kawaguchi Y. Cellular Transcriptional Coactivator RanBP10 and Herpes Simplex Virus 1 ICP0 Interact and Synergistically Promote Viral Gene Expression and Replication. Journal of virology 90(6) 3173-86 2016
  43. Shindo K, Kato A, Koyanagi N, Sagara H, Arii J, Kawaguchi Y. Characterization of a Herpes Simplex Virus 1 (HSV-1) Chimera in Which the Us3 Protein Kinase Gene Is Replaced with the HSV-2 Us3 Gene. Journal of virology 90(1) 457-73 2016
  44. Maeda N, Furukawa A, Kakita K, Anada M, Hashimoto S, Matsunaga S, Kuroki K, Ose T, Kato A, Arii J, Kawaguchi Y, Arase H, Maenaka K. Rapid Screening by Cell-Based Fusion Assay for Identifying Novel Antivirals of Glycoprotein B-Mediated Herpes Simplex Virus Type 1 Infection. Biological & pharmaceutical bulletin 39(11) 1897-1902 2016
  45. Liu Z, Kato A, Oyama M, Kozuka-Hata H, Arii J, Kawaguchi Y. Role of Host Cell p32 in Herpes Simplex Virus 1 De-Envelopment during Viral Nuclear Egress. Journal of virology 89(17) 8982-98 2015 (SpotLightとして巻頭で紹介)
  46. Hirohata Y, Arii J, Liu Z, Shindo K, Oyama M, Kozuka-Hata H, Sagara H, Kato A, Kawaguchi Y. Herpes Simplex Virus 1 Recruits CD98 Heavy Chain and β1 Integrin to the Nuclear Membrane for Viral De-Envelopment. Journal of Virology 89(15) 7799-7812 2015
  47. Hirohata Y, Kato A, Oyama M, Kozuka-Hata H, Koyanagi N, Arii J, Kawaguchi Y. Interactome analysis of herpes simplex virus 1 envelope glycoprotein H. Microbiology and immunology 59(6) 331-7 2015
  48. Kobayashi R, Kato A, Oda S, Koyanagi N, Oyama M, Kozuka-Hata H, Arii J, Kawaguchi Y. Function of the Herpes Simplex Virus 1 Small Capsid Protein VP26 Is Regulated by Phosphorylation at a Specific Site. Journal of virology 89(11) 6141-7 2015
  49. Arii J, Hirohata Y, Kato A, Kawaguchi Y. Nonmuscle myosin heavy chain IIb mediates herpes simplex virus 1 entry. Journal of virology 89(3) 1879-88 2015
  50. Mercenne G+, Alam SL+, Arii J, Lalonde MS, Sundquist WI. Angiomotin functions in HIV-1 assembly and budding. eLife 4 2015
  51. Kato A, Arii J, Koyanagi Y, Kawaguchi Y. Phosphorylation of herpes simplex virus 1 dUTPase regulates viral virulence and genome integrity by compensating for low cellular dUTPase activity in the central nervous system. Journal of virology 89(1) 241-8 2015
  52. Fujii H, Kato A, Mugitani M, Kashima Y, Oyama M, Kozuka-Hata H, Arii J, Kawaguchi Y. The UL12 protein of herpes simplex virus 1 is regulated by tyrosine phosphorylation. Journal of virology 88(18) 10624-34 2014
  53. Maruzuru Y, Shindo K, Liu Z, Oyama M, Kozuka-Hata H, Arii J, Kato A, Kawaguchi Y. Role of herpes simplex virus 1 immediate early protein ICP22 in viral nuclear egress. Journal of virology 88(13) 7445-54 2014
  54. Kato A, Hirohata Y, Arii J, Kawaguchi Y. Phosphorylation of herpes simplex virus 1 dUTPase upregulated viral dUTPase activity to compensate for low cellular dUTPase activity for efficient viral replication. Journal of virology 88(14) 7776-85 2014
  55. Liu Z, Kato A, Shindo K, Noda T, Sagara H, Kawaoka Y, Arii J, Kawaguchi Y. Herpes simplex virus 1 UL47 interacts with viral nuclear egress factors UL31, UL34, and Us3 and regulates viral nuclear egress. Journal of virology 88(9) 4657-67 2014
  56. Fujii H, Mugitani M, Koyanagi N, Liu Z, Tsuda S, Arii J, Kato A, Kawaguchi Y. Role of the nuclease activities encoded by herpes simplex virus 1 UL12 in viral replication and neurovirulence. Journal of virology 88(4) 2359-64 2014
  57. Koyanagi N, Imai T, Arii J, Kato A, Kawaguchi Y. Role of herpes simplex virus 1 Us3 in viral neuroinvasiveness. Microbiology and immunology 58(1) 31-7 2014
  58. Imai T, Koyanagi N, Ogawa R, Shindo K, Suenaga T, Sato A, Arii J, Kato A, Kiyono H, Arase H, Kawaguchi Y. Us3 kinase encoded by herpes simplex virus 1 mediates downregulation of cell surface major histocompatibility complex class I and evasion of CD8+ T cells. PloS one 8(8) e72050 2013
  59. Skalicky JJ, Arii J, Wenzel DM, Stubblefield WM, Katsuyama A, Uter NT, Bajorek M, Myszka DG, Sundquist WI. Interactions of the human LIP5 regulatory protein with endosomal sorting complexes required for transport. The Journal of biological chemistry 287(52) 43910-26 2012 (Best of JBC 2012に選出された)
  60. Morita E+, Arii J+, Christensen D, Votteler J, Sundquist WI. Attenuated protein expression vectors for use in siRNA rescue experiments. BioTechniques 1-5 2012
  61. Kato A, Liu Z, Minowa A, Imai T, Tanaka M, Sugimoto K, Nishiyama Y, Arii J, Kawaguchi Y. Herpes simplex virus 1 protein kinase Us3 and major tegument protein UL47 reciprocally regulate their subcellular localization in infected cells. Journal of virology 85(18) 9599-613 2011 (Faculty of 1000 Biologyで 'Recommended' の評価)
  62. Imai T, Arii J, Minowa A, Kakimoto A, Koyanagi N, Kato A, Kawaguchi Y. Role of the herpes simplex virus 1 Us3 kinase phosphorylation site and endocytosis motifs in the intracellular transport and neurovirulence of envelope glycoprotein B. Journal of virology 85(10) 5003-15 2011 (Faculty of 1000 Biologyで 'Must Read' の評価)
  63. Arii J, Goto H, Suenaga T, Oyama M, Kozuka-Hata H, Imai T, Minowa A, Akashi H, Arase H, Kawaoka Y, Kawaguchi Y. Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1. Nature 467(7317) 859-62 2010 (Faculty of 1000 Biologyで 'Must Read' の評価)
  64. Arii J+, Wang J+, Morimoto T, Suenaga T, Akashi H, Arase H, Kawaguchi Y. A single-amino-acid substitution in herpes simplex virus 1 envelope glycoprotein B at a site required for binding to the paired immunoglobulin-like type 2 receptor alpha (PILRalpha) abrogates PILRalpha-dependent viral entry and reduces pathogenesis. Journal of virology 84(20) 10773-83 2010
  65. Azab W, Tsujimura K, Kato K, Arii J, Morimoto T, Kawaguchi Y, Tohya Y, Matsumura T, Akashi H. Characterization of a thymidine kinase-deficient mutant of equine herpesvirus 4 and in vitro susceptibility of the virus to antiviral agents. Antiviral research 85(2) 389-95 2010
  66. Imai T, Sagou K, Arii J, Kawaguchi Y. Effects of phosphorylation of herpes simplex virus 1 envelope glycoprotein B by Us3 kinase in vivo and in vitro. Journal of virology 84(1) 153-62 2010
  67. Wang J, Fan Q, Satoh T, Arii J, Lanier LL, Spear PG, Kawaguchi Y, Arase H. Binding of herpes simplex virus glycoprotein B (gB) to paired immunoglobulin-like type 2 receptor alpha depends on specific sialylated O-linked glycans on gB. Journal of virology 83(24) 13042-5 2009
  68. Morimoto T, Arii J, Tanaka M, Sata T, Akashi H, Yamada M, Nishiyama Y, Uema M, Kawaguchi Y. Differences in the regulatory and functional effects of the Us3 protein kinase activities of herpes simplex virus 1 and 2. Journal of virology 83(22) 11624-34 2009
  69. Arii J, Kato K, Kawaguchi Y, Tohya Y, Akashi H. Analysis of herpesvirus host specificity determinants using herpesvirus genomes as bacterial artificial chromosomes. Microbiology and immunology 53(8) 433-41 2009
  70. Arii J, Uema M, Morimoto T, Sagara H, Akashi H, Ono E, Arase H, Kawaguchi Y. Entry of herpes simplex virus 1 and other alphaherpesviruses via the paired immunoglobulin-like type 2 receptor alpha. Journal of virology 83(9) 4520-7 2009(SpotLightとして巻頭で紹介)
  71. Morimoto T, Arii J, Akashi H, Kawaguchi Y. Identification of multiple sites suitable for insertion of foreign genes in herpes simplex virus genomes. Microbiology and immunology 53(3) 155-61 2009
  72. Kato A+, Arii J+, Shiratori I, Akashi H, Arase H, Kawaguchi Y. Herpes simplex virus 1 protein kinase Us3 phosphorylates viral envelope glycoprotein B and regulates its expression on the cell surface. Journal of virology 83(1) 250-61 2009 (Faculty of 1000 Biologyで 'Must Read' の評価)
  73. Azab W, Kato K, Arii J, Tsujimura K, Yamane D, Tohya Y, Matsumura T, Akashi H. Cloning of the genome of equine herpesvirus 4 strain TH20p as an infectious bacterial artificial chromosome. Archives of virology 154(5) 833-42 2009
  74. Satoh T, Arii J, Suenaga T, Wang J, Kogure A, Uehori J, Arase N, Shiratori I, Tanaka S, Kawaguchi Y, Spear PG, Lanier LL, Arase H. PILRalpha is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein B. Cell 132(6) 935-44 2008
  75. Arii J+, Hushur O+, Kato K, Kawaguchi Y, Tohya Y, Akashi H. Construction of an infectious clone of canine herpesvirus genome as a bacterial artificial chromosome. Microbes and infection 8(4) 1054-63 2006